T. Rowe Price Associates’s Everus Construction Group ECG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.67M Buy
48,067
+6,285
+15% +$650K ﹤0.01% 1381
2025
Q4
$3.58M Buy
41,782
+2,021
+5% +$181K ﹤0.01% 1509
2025
Q3
$3.41M Buy
39,761
+3,393
+9% +$252K ﹤0.01% 1518
2025
Q2
$2.31M Buy
36,368
+612
+2% +$31K ﹤0.01% 1578
2025
Q1
$1.33M Buy
35,756
+3,421
+11% +$184K ﹤0.01% 1806
2024
Q4
$2.13M Buy
+32,335
New +$2.03M ﹤0.01% 1616

Other funds holding ECG

T. Rowe Price Associates's ECG Position: Q1 2026 in Review

T. Rowe Price Associates increased its Everus Construction Group (ECG) stake by 15% in Q1 2026, buying an estimated $650K and bringing the position to 48,067 shares worth $5.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

T. Rowe Price Associates first reported a position in ECG in Q4 2024 and has held it in 6 quarters since. 488 funds tracked by Wall St. Rank hold ECG as of Q1 2026.

  • T. Rowe Price Associates held 48,067 shares of Everus Construction Group worth $5.67M as of Q1 2026.
  • T. Rowe Price Associates bought 6,285 Everus Construction Group shares in Q1 2026, an estimated $650K.
  • Everus Construction Group made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1381 holding.
  • T. Rowe Price Associates first reported a position in Everus Construction Group in Q4 2024 and has held it in 6 quarters since.
  • 488 funds tracked by Wall St. Rank held Everus Construction Group as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.